WebSection 1: Patient Information Section 3: Clinical Information (TO BE COMPLETED BY HEALTHCARE PROVIDER) Section 4: Prescription for OTEZLA® (apremilast) FOR … Webdetermine the patient’s eligibility. PRESCRIPTION Fax this prescription to 1-833-959-1409 RRX v03 Mar 2024 • PO Box 19149, Lenexa, KS 66285 • Phone: 1-800-932-3060 • Fax: 1-833-959-1409 • amgensafetynetfoundation.com Street (PO Box not accepted) Last name First name City State Zip P2 Patient name
PATIENT FACT SHEET Apremilast (Otezla)
Webimportant risks of Otezla, how these risks can be minimized, and how more information will be obtained about Otezla’s risks and uncertainties (missing information). Otezla’s summary of product characteristics (SmPC) and its package leaflet give essential information to healthcare professionals and patients on how Otezla should be used. WebOtezla should be dose reduced to 30 mg once daily in patients with severe renal impairment (see sections 4.2 and 5.2). Underweight patients Patients who are underweight at the start of treatment should have their body weight monitored regularly. In the event of unexplained and clinically significant weight loss, these patients should be fullcontrol network inc
Apremilast (Otezla®) Drug Information Sheet • Johns Hopkins …
WebSee 17 for PATIENT COUNSELING INFORMATION Revised: 10 12 12.3. 13 14.1 16 ... Before using OTEZLA in patients with a history of depression and/or suicidal thoughts or behavior prescribers should carefully weigh the risks and benefits of treatment with OTEZLA in such patients. Patients, their caregivers, and families should be advised of the need to WebMar 29, 2024 · Otezla is indicated for the treatment of moderate to severe chronic plaque psoriasis in adult patients who failed to respond to or who have a contraindication to, or … WebPrinted name of patient Signature of patient (or legal guardian) Printed name of legal guardian (if applicable) Dated MM/DD/YYYY RRX v03 Mar 2024 • PO Box 19149, … gina thumbs down gif